[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.34 número3
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.34 número3" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.34 número3".
Rev. Bras. Hematol. Hemoter. vol.34 número3
... It is also worth remembering that, with the size of the population, it may be more worthwhile for drugs to be authorized in developing countries than in the developed countries - in th[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número3
... 6. Santos FW, Magalhães SM, Mota RM, Pitombeira MH. Post- transfusion red alloimmunization in patients with acute disorders and medical emergencies. Rev Bras Hematol Hemoter. ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.34 número3 pt v34n3a05
... 7. Santos FW, Magalhães SM, Mota RM, Pitombeira MH. Post-transfu- Post-transfu- sion red alloimmunization in patients with acute disorders and medical emergencies. Rev Bras Hematol Hemoter. ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número3
... The following figure replaces Figure 1 incorrectly published in the Letter to editor “Survival of patients diagnosed with subsets of lymphoid neoplasms and acute myeloi[r] ... See full document
1
Rev. Bras. Hematol. Hemoter. vol.34 número3
... I always remember this forcefulness in private conversations and in the first meetings in Ribeirão Preto which helped him to decide to work with the treatment of chronic autoimmune di[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número3
... Figure 1 - Bone marrow replaced with metastatic breast ductal carcinoma, H&E stain, original magnification 200X. Figure 2 - GCDFP-15 positive breast ductal carcinoma metastat[r] ... See full document
1
Rev. Bras. Hematol. Hemoter. vol.34 número3
... case, the occurrence of monocytes with phenotypical alterations in the bone marrow, dysgranulopoiesis and dysplasia in the monocytic series of the peripheral blood point to a d[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.34 número3
... Quality of biotechnological products: viral safety evaluation of biotechnology product derived from cell lines in of human or animal origin (CPMP/ ICH/295/95) [Internet]. Europe[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número3
... The following examples of treatments can be highlighted: phenothiazine stains such as methylene blue (MB), for viral inactivation of plasma components and derivatives; psorolens [r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número3
... Autologous stem cell transplantation in elderly patients (> or = 60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplanta[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.34 número3
... The first is the use of adult stem cells (bone marrow-derived) that are administered intravitreally and the other technique is the use of embryonic stem cell-derived retinal pigm[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número3
... associated with HIV infection at the clinical screening stage (gender, age, schooling, marital status, place of residence and donation type) and those at the serologica[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número3
... Objective: To implement genotyping for S, s and U antigens of the MNS blood group system at the Fundação Hemominas and to evaluate the occurrence of GYPB gene polymorphisms associated [r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número3
... The presence of antiplatelet antibodies due to an incompatibility between platelet donor and recipient or between mother and fetus during pregnancy is associated to platelet [r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.34 número3
... Ninety (94%) of the 96 children experienced at least one acute event. Clinical manifestations occurred from age 2-79 months and were more frequent among younger children. Table 1 shows the distribution of clinical events ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.34 número3
... The aim of this study was to carry out serological screening to detect IgG and IgM antibodies specific to the four dengue serotypes in blood donors of the transfusion service of[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.34 número3
... Conclusion: On comparing Group A with Group B, the authors concluded that the protocol of respiratory physiotherapy applied in this study resulted in an improvement in v[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.34 número3
... More precisely, the question may now be raised as to how precisely these findings may be used to construct an index from the routine clinical screening data which estimates[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número3
... 3. Silva Filho IL, Ribeiro GS, Moura PG, Vechi ML, Cavalcante AC, Andrada-Serpa MJ. Sickle cell disease: Acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.34 número3
... In this context, the analysis of blood group variants in a specific population is very important to predict a red cell phenotype using molecular methods.. The more we lear[r] ... See full document
2
temas relacionados